产品库

MLN8237 (Alisertib),目录号 S1133,CAS号:1028486-01-2,Aurora Kinase YZ剂,美国Selleck现货供应

产品信息
  • 信号转导通路:  HDAC-HSP-Aurora >> Aurora Kinase >> Aurora Kinase YZ剂 >> 
    技术数据:
    分子量(MW): 518.92
    化学式:

    C27H20ClFN4O4

    溶解度: DMSO ≥44mg/mL   Water <1mg/mL   Ethanol <1mg/mL
    纯度: >99%
    稳定性: at -20℃ 2 years
    CAS号: 1028486-01-2
    生物活性

    MLN8237是Aurora A选择性的次代YZ剂,在酶活实验和细胞实验时IC50都为1nM。在异种移植鼠模型中MLN8237YZ肿瘤生长。[1]MLN8237YZCCRF-CEM细胞生长,实验72小时时IC50达到18.9nM。MLN8237YZMT-4细胞生长,实验72小时时IC50达到7.2 nM。MLN8237YZHUT-102细胞生长,实验72小时时IC50达到6.8 nM。[2] MLN8237可以口服且很快被吸收,可以降低苯二氮等镇静药对神经系统的影响。恶性血液肿瘤是严重影响血液,,淋巴结的一类癌症。MLN8237用于ZL恶性血液肿瘤已经处于一期阶段。[3]MLN8237Z初是由Millennium制药公司研究的。

    参考文献

    [1] Güllü Görgün, et al. Blood, June 24, 2010 vol. 115 no. 25 5202-5213
    [2] Mariko Tomita,et al. Cancer Science ,Volume 101, Issue 5, pages 1204–1211, May 2010
    [3] http://clinicaltrials.gov/ct2/results?term=MLN8237

    客户反馈数据

    Inhibition of Aurora A (12.5 nM) by MLN8054 or MLN8237 was assessed in duplicate radiometric assays containing 100 ]M [γ-32P] ATP and quantified by p81 phosphocellulose assay and scintillation counting. Kinase activity is reported as a percentage of control calculated from duplicate incubations containing 2.5% (v/v) DMSO. IC50 values represent the mean ± SEM calculated from two independent experiments.

     

     

    The effects of T217D and T217N Aurora A mutations were directly compared to WT Aurora A-expressing cells. Each well was treated with either DMSO or 500 nM MLN8054 (E), or 30 nM MLN8237 (F) on day one of the experiment and cells were cultured for 8 days, at which point they were fixed. For all colony assays, an area encompassing >90 % of the colonies per dish is shown. Similar results were seen in two independent duplicate experiments.

    NUSAP mitotic phosphorylation at Ser 240 correlates with Aurora A activity. Protein samples of FLAG–NUSAP immunoprecipitated from I, M and MtMLN or with MtZM were analysed using LC-MS/MS, focusing on the predicted phosphorylated residue Ser 240. The histograms (A, B) show the calculated ratios based on peptides carrying the phosphorylated Ser 240 compared with all matched peptides containing this residue.

     

     

    如果需要长期保存,请于零下二十度低温保存。
    禁止用于人体及ZL!

    特定的存储和包装每个产品的信息在产品说明书上都有注明 。大多数Selleck产品,在推荐的条件下存储可稳定保存两年。产品有时建议的储存温度不同,大多数建议储存在-20 ° C ,抗体及蛋白等产品建议-60℃。YZ剂属于化学试剂,可在常温下运输储存两周左右。即使如此,我们保证产品的出货量将保持产品质量的条件下,一般都会放入冰袋。望阁下收到产品后,请按照产品数据表建议适当存储。



    退换货政策         
     1、 退换货只针对已付款用户。一张订单Selleck只提供一次退换货服务,为了确保您的权益,请考虑周全后与我们联系。         
     2、请您确保退换货时,商品、配件、赠品及各种包装完整。         
     3、因您个人原因造成的商品损坏(如自行使用、分装、受潮、变质、非原物品的等)将不予退换。           
     4、Selleck目前只支持商品一换一服务,换货时无法加定商品。         
     5、如您购买商品时Selleck上海办事处已向您提供发票,则办理退货或订单金额发生变更的换货时,请将发票随商品一同返还给Selleck上海办事处赛导通生物科技(南京)有限公司,请您妥善保管发票,如发票丢失,将无法办理退换货。         
     6、您的订单若办理退换货,运费金额会在您的实际退款中扣除。
    温馨提示:不可用于临床ZL。
  • 信息声明:本产品供应信息由仪器网为您整合,供应商为(赛导通生物科技(南京)有限公司),内容包括 (MLN8237 (Alisertib),目录号 S1133,CAS号:1028486-01-2,Aurora Kinase YZ剂,美国Selleck现货供应)的品牌、型号、技术参数、详细介绍等;如果您想了解更多关于 (MLN8237 (Alisertib),目录号 S1133,CAS号:1028486-01-2,Aurora Kinase YZ剂,美国Selleck现货供应)的信息,请直接联系供应商,给供应商留言!
    供应商产品推荐
      您可能感兴趣的产品